On the stock market since 2019, it operates in the world of money and finance. Now — the numbers.
The company is still in the product-building phase: its spending runs above its sales. That only changes once the product starts selling at scale.
An average decline of 31% a year over the last 4 years — the most striking risk in this picture. Red columns mark years that ended in a loss.
An investor who bought at the very peak is down 87% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
Sales run at $818K a year. A small number, but proof the product has real buyers.
A loss of $0 against $818K in annual sales. And on top of that, sales fell from the year before.
The stock sits at $0.04. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.
On our five-subject report card, ABSOF sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.
The takeaway: ABSOF is a high-risk stock — not yet profitable, and its future rides on its product catching on.